NR4A1 and breast cancer: The basal-like breast cancer subtype, commonly known as triple-negative breast cancer (TNBC), is the most aggressive subtype of breast cancer, characterized by remission, and it defiles several treatment options as they lack all of the three types of hormone receptors that are often targeted for breast cancer treatments.